STOMATOLOGICAL MANAGEMENT IN THE PATIENT WITH SJÖGREN'S SYNDROME

Abstract

Abstract

Introduction: Sjögren's syndrome is an autoimmune disease characterized by a chronic inflammatory process of the exocrine glands, the phenotypic manifestation of which is keratoconjunctivitis sicca and xerostomia, with a rampant tendency to develop cavities, periodontal disease and bacterial and fungal infections.

Objective: To determine the stomatological treatment with the best therapeutic result in the Patient with Sjögren's Syndrome.

Materials and methods: This research work has a retrospective qualitative approach with a descriptive design. The study was based on the analysis of 20 articles from Case Reports, which were obtained
through searches in Pubmed, ProQues,Google Scholar.

Results: A total of 48 patientswere obtained from the Case Reports with Sjögren Syndrome: 38 (79.17%) female and 10 (20.83%) male, with an average age of 27 years, a minimum age of 3 years and a maximum age of 65 years. There were 43 (89.58%) cases with PrimarySjögren's Syndrome and 5 (10.42%) with secondary. The most prevalent clinical characteristics were xerophthalmia with 33
(68.75%)and xerostomia in 46 (95.83%). Hydroxychloroquine was the most used drug in 33 (68.75%) patients and in oral treatment with
greater efficiency was pilocarpine.

Conclusion: The best care is to treat patients with Sjögren's disease in a multidisciplinary way with measures to improve qualityof life, pharmacological and non-pharmacological treatments to keep
diseaseactivity under control.